For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump’s State of the Union: A closer look at the claims
Last night, President Trump delivered a State of the Union address filled with optimism, applause lines, and bold claims about the country’s direction. There…
Citation
‘Just the beginning of enormous growth’: White House heralds strong jobs report
The Black Chronicle cited CEI’s expert on job growth in healthcare Senior Economist with the Competitive Enterprise Institute Ryan Young also interpreted the siloed…
Blog
FDA’s Moderna decision demonstrates how science and government are incompatible
Last week, the FDA announced that it would not be considering Moderna’s application for a new flu vaccine because the control group Moderna used…
Search Posts
The Wall Street Journal
The White House Prepared for a Pandemic
New York Gov. Andrew Cuomo launched the Democrats’ broadside against the Trump administration’s Covid-19 response. “Our current federal government is dysfunctional and incompetent,” he told…
Letters
CEI Joins Coalition Letter Opposing Most Favored Nation Drug Pricing Proposal
On behalf of the undersigned federal and state-based organizations, we write to express our grave concerns with the “most favored nation” (MFN) executive order to impose foreign…
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
Inside Sources
Government Contact Tracing Won’t Help Get Americans Back to Work, but Innovation Will
Contact tracing identifies people who have an infectious disease (cases) and people they came in contact with (contacts) who may have become infected.
News Release
Price Controls for Medicines Risk Harming Innovation When Breakthrough Drugs or Vaccines May Mean Life or Death
President Trump is expected to issue an executive order today directing his administration to take a series of actions related to pharmaceuticals and the price…
Study
#NeverNeeded Price Gouging Laws Would Harm COVID-19 Response
Price gouging becomes a hot topic during every crisis. It has become especially topical during the COVID-19 crisis. Almost overnight, the need exploded for goods…
